Toward quantification of loop diuretic responsiveness for congestive heart failure

por Oyama, Mark A., Adin, Darcy
Publicado 2022

General Commentary: Rethinking the role of animals in human well-being

por Oyama, Mark A., Serpell, James A.
Publicado 2013

Echocardiographic and biomarker evidence of plasma volume expansion after short‐term steroids administered orally in cats

por Block, Chloё L., Oyama, Mark A.
Publicado 2019

Letter regarding “Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial”...

por Oyama, Mark A., Gelzer, Anna R., Kraus, Marc S.
Publicado 2021

Echocardiographic indices and severity of mitral regurgitation in dogs with preclinical degenerative mitral valve disease

por Larouche‐Lebel, Éva, Loughran, Kerry A., Oyama, Mark A.
Publicado 2019

Effect of prespecified therapy escalation on plasma NT‐proBNP concentrations in dogs with stable congestive heart failure due to myxomatous mitral valve disease

por Hezzell, Melanie J., Block, Chloë L., Laughlin, Danielle S., Oyama, Mark A.
Publicado 2018

Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease

por Larouche‐Lebel, Éva, Loughran, Kerry A., Huh, Terry, Oyama, Mark A.
Publicado 2020

Effect of angiotensin receptor blockers and angiotensin‐converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in cats with heart disease

por Huh, Terry, Larouche‐Lebel, Éva, Loughran, Kerry A., Oyama, Mark A.
Publicado 2020

Utility of radiographic measurements to predict echocardiographic left heart enlargement in dogs with preclinical myxomatous mitral valve disease

por Poad, Megan H., Manzi, Timothy J., Oyama, Mark A., Gelzer, Anna R.
Publicado 2020

Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study

por Besche, Beatrice, Blondel, Thomas, Guillot, Emilie, Garelli‐Paar, Catherine, Oyama, Mark A.
Publicado 2020

Behavior in dogs with spontaneous hypothyroidism during treatment with levothyroxine

por Hrovat, Alenka, De Keuster, Tiny, Kooistra, Hans S., Duchateau, Luc, Oyama, Mark A., Peremans, Kathelijne, Daminet, Sylvie
Publicado 2018

Prediction and measurement of diuretic responsiveness after oral administration of furosemide to healthy dogs and dogs with congestive heart failure

por Loughran, Kerry A., Larouche‐Lebel, Éva, Huh, Terry, Testani, Jeffrey M., Rao, Veena S., Oyama, Mark A.
Publicado 2020

Metabolomics Analysis Reveals Deranged Energy Metabolism and Amino Acid Metabolic Reprogramming in Dogs With Myxomatous Mitral Valve Disease

por Li, Qinghong, Larouche‐Lebel, Éva, Loughran, Kerry A., Huh, Terry P., Suchodolski, Jan S., Oyama, Mark A.
Publicado 2021

Gut Dysbiosis and Its Associations with Gut Microbiota-Derived Metabolites in Dogs with Myxomatous Mitral Valve Disease

por Li, Qinghong, Larouche-Lebel, Éva, Loughran, Kerry A., Huh, Terry P., Suchodolski, Jan S., Oyama, Mark A.
Publicado 2021

The use of focused cardiac ultrasound to screen for occult heart disease in asymptomatic cats

por Loughran, Kerry A., Rush, John E., Rozanski, Elizabeth A., Oyama, Mark A., Larouche‐Lebel, Éva, Kraus, Marc S.
Publicado 2019

Optimal rate control in dogs with atrial fibrillation—ORCA study—Multicenter prospective observational study: Prognostic impact and predictors of rate control

por Pedro, Brigite, Mavropoulou, Antonia, Oyama, Mark A., Linney, Christopher, Neves, João, Dukes‐McEwan, Joanna, Fontes‐Sousa, Ana P., Gelzer, Anna R.
Publicado 2023

Plasma and tissue angiotensin‐converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease

por Larouche‐Lebel, Éva, Loughran, Kerry A., Oyama, Mark A., Solter, Phil F., Laughlin, Danielle S., Sánchez, Melissa D., Assenmacher, Charles‐Antoine, Fox, Philip R., Fries, Ryan C.
Publicado 2019

ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs

por Keene, Bruce W., Atkins, Clarke E., Bonagura, John D., Fox, Philip R., Häggström, Jens, Fuentes, Virginia Luis, Oyama, Mark A., Rush, John E., Stepien, Rebecca, Uechi, Masami
Publicado 2019

Effect of a specially formulated diet on progression of heart enlargement in dogs with subclinical degenerative mitral valve disease

por Oyama, Mark A., Scansen, Brian A., Boswood, Adrian, Goldfeder, Guilherme, Rosenthal, Steven, Cober, Richard, LaFauci, Kendra, Friese, Ryan C., Gomes, Márcia, Chang, Yu‐Mei Ruby, Li, Qinghong
Publicado 2023

Accuracy of history, physical examination, cardiac biomarkers, and biochemical variables in identifying dogs with stage B2 degenerative mitral valve disease

por Wilshaw, Jenny, Rosenthal, Steven L., Wess, Gerhard, Dickson, Dave, Bevilacqua, Luca, Dutton, Emily, Deinert, Michael, Abrantes, Ricardo, Schneider, Ingo, Oyama, Mark A., Gordon, Sonya G., Elliott, Jonathan, Xia, Dong, Boswood, Adrian
Publicado 2021